First degree AV block
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3], Ahmed Elsaiey, MBBCH [4], Mohammed Salih, M.D.
Synonyms and keywords: First degree atrioventricular block, first degree AVB, first-degree atrioventricular block, first-degree AV block, first-degree AVB, 1st degree heart block, 1st degree AV block
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Mohammed Salih, M.D., Cafer Zorkun, M.D., Ph.D. [3], Ahmed Elsaiey, MBBCH [4]
Overview
First-degree AV block is a disease of the electrical conduction system of the heart in which the PR interval is prolonged. It is defined as PR prolongation of more than 200 milliseconds (normal PR interval is between 120 and 200 msec). First-degree AV block was first described by Dr. Engelmann in 1984. Dr. Ashmar further studied the blocked impulses and their impact on the conduction in the myocardium. The atrioventricular node is a normal electrical pathway between the atria and ventricles and it is located in the right atrium. First-degree AV block pathogenesis can be attributed to an electrical conduction delay in the AV node or His-Purkinje system. First-degree AV block can be associated with normal QRS complex or wide QRS complex on the ECG. It usually involves the atrioventricular node, but it can involve other structures. In first-degree AV block, all atrial impulses are conducted to the ventricles; however, there is a delay in conduction within the AV node resulting in a prolonged PR interval on ECG (>200 msec or >5 small blocks). In other words, a first-degree AV block is a slowed conduction without loss of atrioventricular synchrony. Common causes of first-degree AV block include ischemic heart disease, congenital heart disease, electrolyte abnormalities (particularly hypokalemia and hypomagnesemia), inflammation, infections (endocarditis, rheumatic fever, Chagas disease, Lyme disease, diphtheria), drugs (antiarrhythmic Ia, Ic, II, III, IV and digoxin, β-blockers, calcium channel blockers ), infiltrative diseases (sarcoidosis), collagen vascular diseases (SLE, rheumatoid arthritis, scleroderma), idiopathic degenerative diseases (Lenegre and Lev diseases) and neuromuscular disorders and increased vagal tone in younger patients. First-degree AV block should be differentiated from third-degree AV block, second degree AV block, supraventricular tachycardia with long PR. The prevalence of First-degree AV block is approximately 1000-2000 per 100,000 individuals in developed countries. The incidence of First-degree AV block was estimated to be 1000 cases per 100,000 in children and adolescent athletes and significantly lower than adults due to lower vagal tone in children. First-degree AV block is more commonly observed among elderly patients. Men are more commonly affected with first-degree AV block than women. The male to female ratio is approximately 2 to 1. First-degree AV block was more commonly observed among African-American subjects compared with Caucasian subjects. Common risk factors associated with atioventricular block include older age, male sex, history of myocardial infarction, history of congestive heart disease , high systolic blood pressure, increased fasting blood glucose level. Ambulatory electrocardiographic monitoring is useful for screening of intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients. In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended. Screening for congenital heart block is recommended in pregnant women with Ro/SSA antibodies. Women with history of neonatal lupus, fetal echos are recommended weekly or every other week from week 18 to 28. It is unclear how often first degree heart block progresses to complete heart block, some cases my revert to normal sinus rhythm or complete heart block.First-degree atrioventricular block may be due to conduction delay in the atrium, atrioventricular node, and/or His-Purkinje system. The atrioventricular node is the site most commonly involved in adults. However, more than 1 site of conduction delay is often present. Isolated First-degree atrioventricular has few clinical consequences. There are no symptoms or signs associated with it. First-degree AV block rarely progresses to more severe form of conduction abnormalities. In the setting of neuromuscular diseases such as myotonic dystrophy 1 with conduction abnormalities in the heart, First-degree AV block may progress to complete heart block during variable period of time. Common complications associated with first-degree heart block may include increased risk of atrial fibrillation, increased risk of pacemaker implantation. Prognosis of First degree AV block is generally good. However, some studies showed worse prognosis with PR prolongation. Presence of First degree AV block is shown to be associated with a higher risk of cardiovascular and all-cause mortality as well as higher risk of heart failure, left ventricular dysfunction, and atrial fibrillation. Symptoms related to atrioventricular block vary and related to the degree of atrioventricular block, the ventricular rate, and the frequency of its occurrence. Patients presented with First-degree AV block are usually asymptomatic. However, severe first-degree AV block may cause symptoms similar to pace maker syndrome including heart failure symptoms, exertional intolerance. Pseudo pacemaker syndrome is defined when the PR interval is >300ms leading to atrial contraction during the closed atrioventricular valves, loss of atrioventricular synchrony and decrease in cardiac output and an increase pulmonary capillary wedge pressure.First degree AV block may be an incidental finding on an routine ECG. General assessment about signs of underlying cardiac disease including auscultation for murmurs or additional heart sounds, assessment of JVD, peripheral edema, evaluation of skin about cyanosis, clubbing, or other signs of cardiac disease is warranted. There are no specific laboratory findings associated with First-degree AV block. However, in suspicion of underlying causes of atrioventricular block, laboratory testing about metabolic disorder, infectious disease, rheumatology disorder is reasonable. Echocardiography is useful for finding structural heart disease in patients with First-degree AV block while symptoms suspected to be cardiac in origin including syncope, presyncope, lightheadedness.In the presence of atrioventricular block and evidence of structural heart disease, cardiac imaging is considered. However, routine cardiac imaging is not recommended in patients with asymptomatic first-degree atrioventricular block and no clinical evidence of structural heart disease.The presence of severe first-degree atrioventricular block (PR >0.30 s) and a narrow QRS usually indicates atrioventricular node delay. However, ambulatory ECG monitoring is useful for finding the alternative changes in QRS morphology. In addition, exercise stress test can be used to identify the ischemia as the precursor of the development of atrioventricular block.Commonly, there is no need for treating first-degree AV block. Permanent pacemaker indicates only for symptomatic first-degree AV block with PR>300 ms,neuromuscular disease, or in presence of wide QRS compelex. First-degree AV block in the setting of acute myocardial infarction usually reverses after recovery from acute phase of myocardial infarction. Antiarrhythmic medications should be avoided in first-degreeAV block.Common factors associated with placement of permanent pacemaker include presence or absence of symptoms, level of atrioventricular block, unstable scaped ventricular rhythm with rapid progression to complete heart block. First-degree AV block is typically a benign condition that do not progress suddenly to complete heart block. Placement of permanent pacemaker is reserved for the condition that symptomatic First-degree AV block affects quality of life as well as evidence of atrioventricular block in neurologic conditions with Lamin A/C mutation ( limb girdle, emery dreifuss, muscular dystrophies). Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels. There are no established measures for the secondary prevention of first-degree heart block.
Historical Perspective
First-degree AV block was first described by Dr. Engelmann in 1984. Dr. Ashmar further studied the blocked impulses and their impact on the conduction in the myocardium.
Classification
There is no established system for the classification of First degree AV block.
Pathophysiology
The atrioventricular node is a normal electrical pathway between the atria and ventricles and it is located in the right atrium. First-degree AV block pathogenesis can be attributed to an electrical conduction delay in the AV node or His-Purkinje system. First-degree AV block can be associated with normal QRS complex or wide QRS complex on the ECG.
Causes
Common causes of first-degree AV block include ischemic heart disease, congenital heart disease, electrolyte abnormalities (particularly hypokalemia and hypomagnesemia), inflammation, infections (endocarditis, rheumatic fever, Chagas disease, Lyme disease, diphtheria), drugs (antiarrhythmic Ia, Ic, II, III, IV and digoxin, β-blockers, calcium channel blockers ), infiltrative diseases (sarcoidosis), collagen vascular diseases (SLE, rheumatoid arthritis, scleroderma), idiopathic degenerative diseases (Lenegre and Lev diseases) and neuromuscular disorders and increased vagal tone in younger patients.
Differentiating First Degree AV block from Other Diseases
First-degree AV block should be differentiated from [[third-degree AV block], second degree AV block, supraventricular tachycardia with long PR.
Epidemiology and Demographics
The prevalence of First-degree AV block is approximately 1000-2000 per 100,000 individuals in developed countries. The incidence of First-degree AV block was estimated to be 1000 cases per 100,000 in children and adolescent athletes and significantly lower than adults due to lower vagal tone in children. First-degree AV block is more commonly observed among elderly patients. Men are more commonly affected with first-degree AV block than women. The male to female ratio is approximately 2 to 1. First-degree AV block was more commonly observed among African-American subjects compared with Caucasian subjects.
Risk Factors
Common risk factors associated with atioventricular block include older age, male sex, history of myocardial infarction, history of congestive heart disease , high systolic blood pressure, increased fasting blood glucose level.
Screening
Ambulatory electrocardiographic monitoring is useful for screening of intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients. In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended. Screening for congenital complete heart block is recommended in pregnant women with Ro/SSA antibodies. Women with history of neonatal lupus, fetal echos are recommended weekly or every other week from week 18 to 28. It is unclear how often first degree heart block progresses to complete heart block, some cases my revert to normal sinus rhythm or complete heart block.
Natural History, Complications, and Prognosis
First-degree atrioventricular block may be due to conduction delay in the atrium, atrioventricular node, and/or His-Purkinje system. The atrioventricular node is the site most commonly involved in adults. However, more than 1 site of conduction delay is often present. Isolated First-degree atrioventricular has few clinical consequences. There are no symptoms or signs associated with it. First-degree AV block rarely progresses to more severe form of conduction abnormalities. In the setting of neuromuscular diseases such as myotonic dystrophy 1 with conduction abnormalities in the heart, First-degree AV block may progress to complete heart block during variable period of time. Common complications associated with first-degree heart block may include increased risk of atrial fibrillation, increased risk of pacemaker implantation. Prognosis of First degree AV block is generally good. However, some studies showed worse prognosis with PR prolongation. Presence of First degree AV block is shown to be associated with a higher risk of cardiovascular and all-cause mortality as well as higher risk of heart failure, left ventricular dysfunction, and atrial fibrillation.
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Symptoms related to atrioventricular block vary and related to the degree of atrioventricular block, the ventricular rate, and the frequency of its occurrence. Patients presented with First-degree AV block are usually asymptomatic. However, severe first-degree AV block may cause symptoms similar to pace maker syndrome including heart failure symptoms, exertional intolerance. Pseudo pacemaker syndrome is defined when the PR interval is >300ms leading to atrial contraction during the closed atrioventricular valves, loss of atrioventricular synchrony and decrease in cardiac output and an increase pulmonary capillary wedge pressure.
Physical Examination
First degree AV block may be an incidental finding on an routine ECG. General assessment about signs of underlying cardiac disease including auscultation for murmurs or additional heart sounds, assessment of JVD, peripheral edema, evaluation of skin about cyanosis, clubbing, or other signs of cardiac disease is warranted.
Laboratory Findings
There are no specific laboratory findings associated with First-degree AV block. However, in suspicion of underlying causes of atrioventricular block, laboratory testing about metabolic disorder, infectious disease, rheumatology disorder is reasonable.
Electrocardiogram
In normal individuals, the AV node slows the conduction of electrical impulse through the heart. This is manifest on a surface EKG as the PR interval. The normal PR interval is from 120 milliseconds (ms) to 200 milliseconds (ms) in duration. This is measured from the initial deflection of the P wave to the beginning of the QRS complex.
In first degree heart block, the diseased AV node conducts the electrical activity slower. This is seen as a PR interval greater than 200 milliseconds (ms) in length on the surface EKG. It is usually an incidental finding on a routine EKG.
First degree heart block does not require any particular evaluation except for electrolyte and drug screens especially if an overdose is suspected.
X-ray
There are no x-ray findings associated with first degree AV block.
Echocardiography is useful for finding structural heart disease in patients with First-degree AV block while symptoms suspected to be cardiac in origin including syncope, presyncope, lightheadedness.
Other Imaging Findings
In the presence of atrioventricular block and evidence of structural heart disease, cardiac imaging is considered. However, routine cardiac imaging is not recommended in patients with asymptomatic first-degree atrioventricular block and no clinical evidence of structural heart disease.
Other Diagnostic Studies
The presence of severe first-degree atrioventricular block (PR >0.30 s) and a narrow QRS usually indicates atrioventricular node delay. However, ambulatory ECG monitoring is useful for finding the alternative changes in QRS morphology. In addition, exercise stress test can be used to identify the ischemia as the precursor of the development of atrioventricular block.
Treatment
Medical Therapy
Commonly, there is no need for treating first-degree AV block. Permanent pacemaker indicates only for symptomatic first-degree AV block with PR>300 ms,neuromuscular disease, or in presence of wide QRS compelex. First-degree AV block in the setting of acute myocardial infarction usually reverses after recovery from acute phase of myocardial infarction. Antiarrhythmic medications should be avoided in first-degreeAV block.
Surgery
Common factors associated with placement of permanent pacemaker include presence of symptoms, level of atrioventricular block, unstable scaped ventricular rhythm with rapid progression to complete heart block. First-degree AV block is typically a benign condition that do not progress suddenly to complete heart block. Placement of permanent pacemaker is reserved for the condition that symptomatic First-degree AV block affects quality of life as well as evidence of atrioventricular block in neurologic conditions with Lamin A/C mutation ( limb girdle, emery dreifuss, muscular dystrophies).
Primary Prevention
Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels
Secondary Prevention
There are no established measures for the secondary prevention of first-degree heart block.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
First-degree AV block was first described by Dr. Engelmann in 1984. Dr. Ashmar further studied the blocked impulses and their impact on the conduction in the myocardium.
Historical perspective
- In 1894, Dr. Engelmann described a phenomenon of AV interval lengthening. Dr. Engelmann described a stimulus that is applied to the atrium followed by elongation of the AV interval.[1]
- In 1925, Dr. Ashmar further studied these blocked impulses and their impact on the conduction in the muscle of the heart.
- Dr. Ashmar stated the early blocked beats that follow normal impulses have less effect on the conduction system.
References
- ↑ LANGENDORF R (1948). “Concealed A-V conduction; the effect of blocked impulses on the formation and conduction of subsequent impulses”. Am Heart J. 35 (4): 542–52. doi:10.1016/0002-8703(48)90641-3. PMID 18907667.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Salih, M.D., Ahmed Elsaiey, MBBCH [2], Cafer Zorkun, M.D., Ph.D. [3]
Overview
The atrioventricular node is a normal electrical pathway between the atria and ventricles and it is located in the right atrium. First-degree AV block pathogenesis can be attributed to an electrical conduction delay in the AV node or His-Purkinje system. First-degree AV block can be associated with normal QRS complex or wide QRS complex on the ECG.
Pathophysiology
Physiology
- The atrioventricluar node is the normal electrical pathway between the atria and ventricles. It is located in the right atrium near to the tricuspid valve leaflet.
- The AV node receives blood supply from the right coronary artery in most of the population.
- The bundle of His is the electrical connection between the AV node to the interventricular septum. At the end of the septum, a bundle of His is divided into the right and left bundle branches to the ventricular walls.
Pathogenesis
- First-degree AV block broadly means the prolongation of the PR interval on the ECG with normal atrioventricular node function.
- First-degree AV block pathogenesis can be attributed to an electrical conduction delay in one of the following:[1]
- Atrioventricular node
- His-Purkinje system which is formed of both bundle of His and Purkinje fibers
- The conduction delay can be also in both the AV node and His-Purkinje system.
- One of the characteristics of first-degree AV block is that there are no beats skipped and it has a regular rhythm.
First-degree AV Block with Normal QRS Duration
First-degree AV block with normal QRS duration results from atrial or AV nodal delay.
First-degree AV Block with Wide QRS Complex
First-degree AV block with wide QRS complex most often results from delay in conduction in the bundle of His and in some patients, the AV node.
References
- ↑ Lewalter T, Pürerfellner H, Ungar A, Rieger G, Mangoni L, Duru F; et al. (2018). ““First-degree AV block-a benign entity?” Insertable cardiac monitor in patients with 1st-degree AV block reveals presence or progression to higher grade block or bradycardia requiring pacemaker implant”. J Interv Card Electrophysiol. 52 (3): 303–306. doi:10.1007/s10840-018-0439-7. PMID 30105427.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Common causes of first-degree AV block include ischemic heart disease, congenital heart disease, electrolyte abnormalities (particularly hypokalemia and hypomagnesemia), inflammation, infections (endocarditis, rheumatic fever, Chagas disease, Lyme disease, diphtheria), drugs (antiarrhythmic Ia, Ic, II, III, IV and digoxin, β-blockers, calcium channel blockers ), infiltrative diseases (sarcoidosis), collagen vascular diseases (SLE, rheumatoid arthritis, scleroderma), idiopathic degenerative diseases (Lenegre and Lev diseases) and neuromuscular disorders and increased vagal tone in younger patients.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
- Hyperkalemia
- Hyperthyroidism
- Hypothyroidism
- Increased vagal tone (e.g. sleep, athletes)
- Ischemic heart disease
- Medications ( e.g. adenosine, amiodarone, beta-blockers, diltiazem, procainamide, verapamil)
Causes by Organ System
Causes in Alphabetical Order
References
Differentiating First degree AV block from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
Overview
First-degree AV block should be differentiated from [[third-degree AV block], second degree AV block, supraventricular tachycardia with long PR.
Differentiating First-degree AV block from other Diseases
First-degree AV block should be differentiated from the following:
following table summarizes the differential diagnosis of First-degree AV block:
| Arrhythmia | Rhythm | Rate | P wave | PR Interval | QRS Complex | Response to Maneuvers | Epidemiology | Co-existing Conditions | |
|---|---|---|---|---|---|---|---|---|---|
| Atrioventricular block[1] | First degree [2][3] |
|
|
|
|
|
|
| |
| Second degree[4][5] |
|
|
|
QRS is normal but dropped as the following:
|
|
| |||
| Third degree[6][7] |
|
|
|
|
|
| |||
| Atrial Fibrillation (AFib)[8][9] |
|
|
|
|
|
|
|
| |
| Atrial Flutter[10] |
|
|
|
|
|
|
|
||
| Atrioventricular nodal reentry tachycardia (AVNRT)[11][12][13][14] |
|
|
|
|
|
|
|
||
| Multifocal Atrial Tachycardia[15][16] |
|
|
|
|
|
|
|
||
| Paroxysmal Supraventricular Tachycardia |
|
|
|
|
|
|
|
||
| Premature Atrial Contractrions (PAC)[17][18] |
|
|
|
|
|
|
|||
| Wolff-Parkinson-White Syndrome[19][20] |
|
|
|
|
|
|
|
| |
| Ventricular Fibrillation (VF)[21][22][23] |
|
|
|
|
|
|
|
| |
| Ventricular Tachycardia[24][25] |
|
|
|
|
|
|
|
| |
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ; et al. (2019). “Risk Factors Associated With Atrioventricular Block”. JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ Barold SS (1996). “Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III?”. Pacing Clin Electrophysiol. 19 (5): 747–51. doi:10.1111/j.1540-8159.1996.tb03355.x. PMID 8734740.
- ↑ Upshaw CB (2004). “Comparison of the prevalence of first-degree atrioventricular block in African-American and in Caucasian patients: an electrocardiographic study III”. J Natl Med Assoc. 96 (6): 756–60. PMC 2568382. PMID 15233485.
- ↑ Zehender M, Meinertz T, Keul J, Just H (1990). “ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance”. Am Heart J. 119 (6): 1378–91. doi:10.1016/s0002-8703(05)80189-9. PMID 2191578.
- ↑ Friedman HS, Gomes JA, Haft JI (1975). “An analysis of Wenckebach periodicity”. J Electrocardiol. 8 (4): 307–15. doi:10.1016/s0022-0736(75)80003-3. PMID 1176840.
- ↑ OSTRANDER LD, BRANDT RL, KJELSBERG MO, EPSTEIN FH (June 1965). “ELECTROCARDIOGRAPHIC FINDINGS AMONG THE ADULT POPULATION OF A TOTAL NATURAL COMMUNITY, TECUMSEH, MICHIGAN”. Circulation. 31: 888–98. doi:10.1161/01.cir.31.6.888. PMID 14297523.
- ↑ Movahed MR, Hashemzadeh M, Jamal MM (October 2005). “Increased prevalence of third-degree atrioventricular block in patients with type II diabetes mellitus”. Chest. 128 (4): 2611–4. doi:10.1378/chest.128.4.2611. PMID 16236932.
- ↑ Lankveld TA, Zeemering S, Crijns HJ, Schotten U (July 2014). “The ECG as a tool to determine atrial fibrillation complexity”. Heart. 100 (14): 1077–84. doi:10.1136/heartjnl-2013-305149. PMID 24837984.
- ↑ Harris K, Edwards D, Mant J (2012). “How can we best detect atrial fibrillation?”. J R Coll Physicians Edinb. 42 Suppl 18: 5–22. doi:10.4997/JRCPE.2012.S02. PMID 22518390.
- ↑ Cosío FG (June 2017). “Atrial Flutter, Typical and Atypical: A Review”. Arrhythm Electrophysiol Rev. 6 (2): 55–62. doi:10.15420/aer.2017.5.2. PMC 5522718. PMID 28835836.
- ↑ Katritsis DG, Josephson ME (August 2016). “Classification, Electrophysiological Features and Therapy of Atrioventricular Nodal Reentrant Tachycardia”. Arrhythm Electrophysiol Rev. 5 (2): 130–5. doi:10.15420/AER.2016.18.2. PMC 5013176. PMID 27617092.
- ↑ Letsas KP, Weber R, Siklody CH, Mihas CC, Stockinger J, Blum T, Kalusche D, Arentz T (April 2010). “Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway”. Acta Cardiol. 65 (2): 171–6. doi:10.2143/AC.65.2.2047050. PMID 20458824.
- ↑ “Atrioventricular Nodal Reentry Tachycardia (AVNRT) – StatPearls – NCBI Bookshelf”.
- ↑ Schernthaner C, Danmayr F, Strohmer B (2014). “Coexistence of atrioventricular nodal reentrant tachycardia with other forms of arrhythmias”. Med Princ Pract. 23 (6): 543–50. doi:10.1159/000365418. PMC 5586929. PMID 25196716.
- ↑ Scher DL, Arsura EL (September 1989). “Multifocal atrial tachycardia: mechanisms, clinical correlates, and treatment”. Am. Heart J. 118 (3): 574–80. doi:10.1016/0002-8703(89)90275-5. PMID 2570520.
- ↑ Goodacre S, Irons R (March 2002). “ABC of clinical electrocardiography: Atrial arrhythmias”. BMJ. 324 (7337): 594–7. doi:10.1136/bmj.324.7337.594. PMC 1122515. PMID 11884328.
- ↑ Lin CY, Lin YJ, Chen YY, Chang SL, Lo LW, Chao TF, Chung FP, Hu YF, Chong E, Cheng HM, Tuan TC, Liao JN, Chiou CW, Huang JL, Chen SA (August 2015). “Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome”. J Am Heart Assoc. 4 (9): e002192. doi:10.1161/JAHA.115.002192. PMC 4599506. PMID 26316525.
- ↑ Strasburger JF, Cheulkar B, Wichman HJ (December 2007). “Perinatal arrhythmias: diagnosis and management”. Clin Perinatol. 34 (4): 627–52, vii–viii. doi:10.1016/j.clp.2007.10.002. PMC 3310372. PMID 18063110.
- ↑ Rao AL, Salerno JC, Asif IM, Drezner JA (July 2014). “Evaluation and management of wolff-Parkinson-white in athletes”. Sports Health. 6 (4): 326–32. doi:10.1177/1941738113509059. PMC 4065555. PMID 24982705.
- ↑ Rosner MH, Brady WJ, Kefer MP, Martin ML (November 1999). “Electrocardiography in the patient with the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues”. Am J Emerg Med. 17 (7): 705–14. doi:10.1016/s0735-6757(99)90167-5. PMID 10597097.
- ↑ Glinge C, Sattler S, Jabbari R, Tfelt-Hansen J (September 2016). “Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction”. J Geriatr Cardiol. 13 (9): 789–797. doi:10.11909/j.issn.1671-5411.2016.09.006. PMC 5122505. PMID 27899944.
- ↑ Samie FH, Jalife J (May 2001). “Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart”. Cardiovasc. Res. 50 (2): 242–50. doi:10.1016/s0008-6363(00)00289-3. PMID 11334828.
- ↑ Adabag AS, Luepker RV, Roger VL, Gersh BJ (April 2010). “Sudden cardiac death: epidemiology and risk factors”. Nat Rev Cardiol. 7 (4): 216–25. doi:10.1038/nrcardio.2010.3. PMC 5014372. PMID 20142817.
- ↑ Koplan BA, Stevenson WG (March 2009). “Ventricular tachycardia and sudden cardiac death”. Mayo Clin. Proc. 84 (3): 289–97. doi:10.1016/S0025-6196(11)61149-X. PMC 2664600. PMID 19252119.
- ↑ Levis JT (2011). “ECG Diagnosis: Monomorphic Ventricular Tachycardia”. Perm J. 15 (1): 65. doi:10.7812/tpp/10-130. PMC 3048638. PMID 21505622.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ahmed Elsaiey, MBBCH [3], Cafer Zorkun, M.D., Ph.D. [4]
Overview
The prevalence of First-degree AV block is approximately 1000-2000 per 100,000 individuals in developed countries. The incidence of First-degree AV block was estimated to be 1000 cases per 100,000 in children and adolescent athletes and significantly lower than adults due to lower vagal tone in children. First-degree AV block is more commonly observed among elderly patients. Men are more commonly affected with first-degree AV block than women. The male to female ratio is approximately 2 to 1. First-degree AV block was more commonly observed among African-American subjects compared with Caucasian subjects.
Epidemiology and Demographics
Prevalence
- The prevalence of First-degree AV block is approximately 1000-2000 per 100,000 individuals in developed countries.[1]
- The incidence of First-degree AV block was estimated to be 1000 cases per 100,000 in children and adolescent athletes and significantly lower than adult due to lower vagal tone.[2]
Age
- First-degree AV block is more commonly observed among elderly patients.
Gender
- Men are more commonly affected with first-degree AV block than women .
- The male to female ratio is approximately 2 to 1.
Race
- First-degree AV block was more commonly observed among African-American subjects compared with Caucasian subjects.[3]
References
- ↑ Bexton RS, Camm AJ (1984). “First degree atrioventricular block”. Eur Heart J. 5 Suppl A: 107–9. doi:10.1093/eurheartj/5.suppl_a.107. PMID 6373267.
- ↑ Velasquez Rodriguez, J; Gonzalez-Saldivar, H; Li, X; Bruna-Fernandez, V; Valero-Masa, M.J; De Hevia, M; Diaz-Gonzalez, L (2020). “First-degree atrioventricular block in children and adolescent athletes”. European Heart Journal. 41 (Supplement_2). doi:10.1093/ehjci/ehaa946.3133. ISSN 0195-668X.
- ↑ Upshaw CB (2004). “Comparison of the prevalence of first-degree atrioventricular block in African-American and in Caucasian patients: an electrocardiographic study III”. J Natl Med Assoc. 96 (6): 756–60. PMC 2568382. PMID 15233485.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ahmed Elsaiey, MBBCH [3]
Overview
Common risk factors associated with atioventricular block include older age, male sex, history of myocardial infarction, history of congestive heart disease , high systolic blood pressure, increased fasting blood glucose level.
Risk factors
- Common risk factors associated with atioventricular block include:[1]
- Older age
- Male sex
- History of myocardial infarction
- History of congestive heart disease
- High systolic blood pressure
- Increased fasting blood glucose level
- Common risk factors associated with atrioventricular block after cardiac surgery include:
- Older age
- Atrial fibrillation
- Prior surgery
- Preoperative renal failure
- Active endocarditis
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ; et al. (2019). “Risk Factors Associated With Atrioventricular Block”. JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Ahmed Elsaiey, MBBCH [3]
Overview
Ambulatory electrocardiographic monitoring is useful for detection of intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients. In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended. Screening for congenital complete heart block is recommended in pregnant women with Ro/SSA antibodies. Women with history of neonatal lupus, fetal echos are recommended weekly or every other week from week 18 to 28. It is unclear how often first degree heart block progresses to complete heart block, some cases my revert to normal sinus rhythm or complete heart block.
Screening
- Ambulatory electrocardiographic monitoring is useful for detection of intermittent atrioventricular block, LBBB and bifascicular block in asymptomatic patients.
- In patients with symptomatic atrioventricular block or bradycardia during sleep, screening about sleep apnea is recommended.[1]
- Screening for congenital complete heart block is recommended in pregnant women with Ro/SSA antibodies.[2]
- Women with history of neonatal lupus, fetal echos are recommended weekly or every other week from week 18 to 28.
- It is unclear how often first degree heart block progresses to complete heart block, some cases my revert to normal sinus rhythm or complete heart block.
| Recommendations for screening sleep apnea in patients with bradycardia or conduction disorder |
| (Class I, Level of Evidence B): |
|
❑ Screening about sleep apnea syndrome is recommended In patients with documented or suspected bradycardia or conduction disorder during sleep |
| (Class IIa, Level of Evidence B): |
|
❑ In patients with previously PPM implantation for bradycardia or conduction disorder, screening about sleep apnea syndrome is reasonable |
| The above table adopted from 2018 AHA/ACC/HRS Guideline[3] |
|---|
References
- ↑ Kasai, Takatoshi; Floras, John S.; Bradley, T. Douglas (2012). “Sleep Apnea and Cardiovascular Disease”. Circulation. 126 (12): 1495–1510. doi:10.1161/CIRCULATIONAHA.111.070813. ISSN 0009-7322.
- ↑ Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). “The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices”. Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.
- ↑ Kusumoto, Fred M.; Schoenfeld, Mark H.; Barrett, Coletta; Edgerton, James R.; Ellenbogen, Kenneth A.; Gold, Michael R.; Goldschlager, Nora F.; Hamilton, Robert M.; Joglar, José A.; Kim, Robert J.; Lee, Richard; Marine, Joseph E.; McLeod, Christopher J.; Oken, Keith R.; Patton, Kristen K.; Pellegrini, Cara N.; Selzman, Kimberly A.; Thompson, Annemarie; Varosy, Paul D. (2019). “2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Circulation. 140 (8). doi:10.1161/CIR.0000000000000628. ISSN 0009-7322.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Cafer Zorkun, M.D., Ph.D. [3]
Overview
First-degree atrioventricular block may be due to conduction delay in the atrium, atrioventricular node, and/or His-Purkinje system. The atrioventricular node is the site most commonly involved in adults. However, more than 1 site of conduction delay is often present. Isolated First-degree atrioventricular has few clinical consequences. There are no symptoms or signs associated with it. First-degree AV block rarely progresses to more severe form of conduction abnormalities. In the setting of neuromuscular diseases such as myotonic dystrophy 1 with conduction abnormalities in the heart, First-degree AV block may progress to complete heart block during variable period of time. Common complications associated with first-degree heart block may include increased risk of atrial fibrillation, increased risk of pacemaker implantation. Prognosis of First degree AV block is generally good. However, some studies showed worse prognosis with PR prolongation. Presence of First degree AV block is shown to be associated with a higher risk of cardiovascular and all-cause mortality as well as higher risk of heart failure, left ventricular dysfunction, and atrial fibrillation.
Natural History
- First-degree atrioventricular block may be due to conduction delay in the atrium, atrioventricular node, and/or His-Purkinje system
- The atrioventricular node is the site most commonly involved in adults. However, more than 1 site of conduction delay is often present.
- Isolated first-degree atrioventricular has few clinical consequences. There are no symptoms or signs associated with it.
- First-degree AV block rarely progresses to more severe form of conduction abnormalities, it is mostly a benign condition in healthy middle-aged men and is not correlated with coronary heart disease.[1]
- In the setting of neuromuscular diseases such as myotonic dystrophy 1 with conduction abnormalities in the heart, First-degree AV block may progress to complete heart block during variable period of time.
Complications
Common complications associated with first-degree heart block may include the following: [2]
- Increased risk of atrial fibrillation
- Increased risk of Pacemaker implantation
- Individuals who have the First-degree block as part of a triad of First-degree heart block, right bundle branch block, and either left anterior fascicular block or left posterior fascicular block (known as trifascicular block) may be at an increased risk of progression to complete heart block.
Prognosis
- Prognosis of first degree AV block is generally good[3]. However, some studies showed worse prognosis with PR prolongation.[4]
- Presence of first degree AV block is shown to be associated with a higher risk of cardiovascular and all-cause mortality.[5]
- In a 2016 meta-analysis, first degree AV block was found to be associated with higher mortality risk. It was also associated with a high risk of heart failure, left ventricular dysfunction, and atrial fibrillation. However, it was not associated with high risk of coronary artery disease, stroke, or myocardial infarction.[6]
References
- ↑ Erikssen J, Otterstad JE (1984). “Natural course of a prolonged PR interval and the relation between PR and incidence of coronary heart disease. A 7-year follow-up study of 1832 apparently healthy men aged 40-59 years”. Clin Cardiol. 7 (1): 6–13. doi:10.1002/clc.4960070104. PMID 6705291.
- ↑ Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ (2009). “Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block”. JAMA. 301 (24): 25712577. doi:10.1001/jama.2009.888.
- ↑ Mymin, David; Mathewson, Francis A.L.; Tate, Robert B.; Manfreda, Jure (1986). “The Natural History of Primary First-Degree Atrioventricular Heart Block”. New England Journal of Medicine. 315 (19): 1183–1187. doi:10.1056/NEJM198611063151902. ISSN 0028-4793.
- ↑ Cheng S, Keyes MJ, Larson MG, McCabe EL, Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS, Wang TJ (2009). “Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block”. JAMA. 301 (24): 25712577. doi:10.1001/jama.2009.888.
- ↑ . doi:10.1016/j.hrthm.2010.09.020.Epub2010Sep22. Missing or empty
|title=(help) - ↑ Kwok CS, Rashid M, Beynon R, Barker D, Patwala A, Morley-Davies A; et al. (2016). “Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis”. Heart. 102 (9): 672–80. doi:10.1136/heartjnl-2015-308956. PMID 26879241.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Chest X Ray | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH


